Skip to main content
. 2017 Jun 9;8:251. doi: 10.3389/fneur.2017.00251

Figure 2.

Figure 2

Glial fibrillary acidic protein immunoreactivity in the hippocampus (A), caudate–putamen (B), frontal lobe (C), and substantia nigra (D), in slices of control (CTR), vehicle of LPS (V-LPS), lipopolysaccharide (LPS), mofezolac and LPS (M-LPS)-treated mice.